Prostate Cancer Clinical Trial
Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer
Summary
The purpose of this study is to assess for changes in a patient's overall energy level and well-being (quality of life) after 8 weeks of dietary intervention.
Full Description
Primary Objective: To assess for changes in the following measurements after 8 weeks of following a Mediterranean diet-- LDL, HDL, TG, FBS, creatinine, serum testosterone, triglycerides, serum insulin, CRP, 1bs, Waist circumference, blood pressure, body weight
Eligibility Criteria
Inclusion Criteria:
Histologically documented carcinoma of the prostate
On treatment with androgen deprivation therapy for at least 3 months
Required laboratory values:
Serum creatinine less than 2.5
Triglycerides <300
Fasting glucose < 126
Testosterone level <50
Exclusion Criteria:
No diabetes mellitus (Type 1 or 2)
No renal failure (Serum creatinine > 2.5)
No active cardiac disease -no history of myocardial infarction/stroke within the last 12 months, no recurrent unstable angina, uncontrolled/unstable arrhythmias, uncontrolled hypertension (systolic blood pressure >160, diastolic blood pressure >100)
No severe peripheral vascular disease
No commencement of lipid lowering agent within 8 weeks of enrollment the study or change in dose throughout the study
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Providence Rhode Island, 02906, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.